Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Accera identifies genetic profile of AD patients with heightened response to Axona

Accera, Inc., a biotech company specializing in cognitive health, announced today that it has identified the genetic profile of Alzheimer’s disease (AD) patients who have a high probability of responding to Axona (AC-1202), a prescription medical food product available at pharmacies nationwide.

18 Oct 2011

HSV1 drugs could slow progression of Alzheimer's disease

Antiviral drugs used to target the herpes virus could be effective at slowing the progression of Alzheimer's disease (AD), a new study shows.

From The University of Manchester 18 Oct 2011

Inhaled anesthetics do not increase incidence of postoperative delirium

A study presented at ANESTHESIOLOGY 2011 in Chicago this week offered firm evidence that commonly used inhaled anesthetics such as isoflurane do not increase the incidence of postoperative delirium, which can affect how well some patients recover after surgery.

18 Oct 2011

Brain tumour discovery offers drug treatment hope

Australian scientists have played a key role in the identification of a new biochemical mechanism that allows brain tumours to survive and grow, offering hope of new drug treatments for some of the most aggressive tumours.

17 Oct 2011

Johns Hopkins Brain Science Institute organizes Drug Discovery in Academia symposium

A symposium to be hosted by the Johns Hopkins Brain Science Institute (BSi) on Oct. 18 at the Baltimore Convention Center will bring together the pharmaceutical industry and academic-based research institutions with the common goal of exploring how the two can best work together to enhance and facilitate the discovery of new drugs.

15 Oct 2011

Obese post-menopausal women outperform normal weight counterparts in cognitive tasks

Obesity has been associated with cognitive decline, characterized by a deterioration of mental abilities that involve memory, language, and thought-processing speed.

14 Oct 2011

First physical evidence that bilingualism delays onset of Alzheimer's

Researchers at St. Michael's Hospital have found that people who speak more than one language have twice as much brain damage as unilingual people before they exhibit symptoms of Alzheimer's disease. It's the first physical evidence that bilingualism delays the onset of the disease.

14 Oct 2011

NIH awards Scripps Research scientist for research into Type I diabetes

A scientist at The Scripps Research Institute has been awarded $4.2 million from the National Institutes of Health in a program to advance what the agency calls "bold and creative research" into Type I diabetes.

14 Oct 2011

NIH awards Salk Institute $4.5M to establish new Neuroscience Core Center

The National Institutes of Health has announced that the Salk Institute will receive $4.5 million to establish a Neuroscience Core Center, a new research center intended to accelerate brain research that lays the foundation for developing new ways to treat congenital brain defects and neurological diseases.

14 Oct 2011

Faster cerebral cortex growth in infancy may lead to higher intelligence

New research suggests the growth rate of the brain's cerebral cortex in babies born prematurely may predict how well they are able to think, speak, plan and pay attention later in childhood. The research is published in the October 12, 2011, online issue of Neurology®, the medical journal of the American Academy of Neurology.

14 Oct 2011

October is designated as Lewy Body Dementia month

The month of October is designated as Lewy Body Dementia month. Lewy body dementia (LBD) is a degenerative brain disease that progressively impairs thinking and movement, while impacting behavior and sleep. Although it affects an estimated 1.3 million people in the U.S., LBD is under-recognized, under-diagnosed and under-treated. It is most often misdiagnosed as Alzheimer's or Parkinson's disease.

13 Oct 2011

AAN Foundation launches new PSA on finding cure for brain disease

With one in six people in the United States now affected by brain disease such as dementia, multiple sclerosis and epilepsy, the American Academy of Neurology Foundation is marking its 20th anniversary with the launch of a new public service announcement (PSA) to raise awareness about the need for more research to cure brain disease.

12 Oct 2011

AFFiRiS receives MJFF grant for clinical study of AFFITOPE PD01

The Michael J. Fox Foundation (MJFF) today announced that it has awarded $1.5 million to AFFiRiS AG, a Vienna, Austria-based biotech company, for a clinical study of AFFITOPE PD01, a first-of-its-kind Parkinson's disease (PD) vaccine.

12 Oct 2011

Journal of Alzheimer's Disease supplement explores neuroimaging

Alzheimer's disease (AD) is a common problem that is becoming progressively burdensome throughout the world. A new supplement to the Journal of Alzheimer's Disease, Imaging the Alzheimer Brain, clearly shows that multiple imaging systems are now available to help understand, diagnose, and treat the disease.

12 Oct 2011

UB scientists discover promising new drug target for Alzheimer's

A tiny piece of a critical receptor that fuels the brain and without which sentient beings cannot live has been discovered by University at Buffalo scientists as a promising new drug target for Alzheimer's and other neurodegenerative diseases.

12 Oct 2011

Viewpoints: The value of testing for prostate cancer; rewards for transplant donors; Calif.'s medical marijuana problem

For men older than 50, a simple blood test to screen for prostate cancer is as much a part of annual physicals as weigh-ins and stethoscopes. The PSA test is painless, inexpensive and the only way to detect the disease - the most common male cancer - before symptoms turn up.

12 Oct 2011

Researchers assess new guidelines for preclinical Alzheimer's disease

Addressing the earliest stages of Alzheimer's disease, before a patient shows outward signs of cognitive problems, has sometimes been a challenge for physicians and researchers, in part because they have not been using common and specific terms to describe the disease's initial phases.

11 Oct 2011

Roche's gantenerumab removes amyloid plaques from the brain of patients with AD

Roche today announced the publication of a study demonstrating that its monoclonal antibody gantenerumab removes amyloid plaques from the brain of patients with Alzheimer's disease. The study "Mechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab" is published today in the October issue of Archives in Neurology.

11 Oct 2011

Gantenerumab appears to reduce brain amyloid levels in patients with AD

Although it is a small study and more clinical trials are needed, treatment with the medication gantenerumab appeared to result in a reduction in brain amyloid levels in patients with Alzheimer disease, according to a report published Online First by Archives of Neurology, one of the JAMA/Archives journals.

11 Oct 2011

Leg-crossers more likely to have good recovery after severe stroke

People who are able to cross their legs soon after having a severe stroke appear to be more likely to have a good recovery compared to people who can't cross their legs.

11 Oct 2011

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Accera identifies genetic profile of AD patients with heightened response to Axona

HSV1 drugs could slow progression of Alzheimer's disease

Inhaled anesthetics do not increase incidence of postoperative delirium

Brain tumour discovery offers drug treatment hope

Johns Hopkins Brain Science Institute organizes Drug Discovery in Academia symposium

Obese post-menopausal women outperform normal weight counterparts in cognitive tasks

First physical evidence that bilingualism delays onset of Alzheimer's

NIH awards Scripps Research scientist for research into Type I diabetes

NIH awards Salk Institute $4.5M to establish new Neuroscience Core Center

Faster cerebral cortex growth in infancy may lead to higher intelligence

October is designated as Lewy Body Dementia month

AAN Foundation launches new PSA on finding cure for brain disease

AFFiRiS receives MJFF grant for clinical study of AFFITOPE PD01

Journal of Alzheimer's Disease supplement explores neuroimaging

UB scientists discover promising new drug target for Alzheimer's

Viewpoints: The value of testing for prostate cancer; rewards for transplant donors; Calif.'s medical marijuana problem

Researchers assess new guidelines for preclinical Alzheimer's disease

Roche's gantenerumab removes amyloid plaques from the brain of patients with AD

Gantenerumab appears to reduce brain amyloid levels in patients with AD

Leg-crossers more likely to have good recovery after severe stroke

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Unlocking live single-cell functional insights

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Unlocking live single-cell functional insights

Newsletters you may be interested in